Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in the United States:
sales of $20.85 billion
of which 33%
Teva Pharmaceutical Industries Limited
Bristol-Myers Squibb Company
of which 100%
Eli Lilly and Company reported sales of $21.22 billion
December of 2016.
increase of 6.3%
versus 2015, when the company's sales were $19.96 billion.